Showing 1 - 20 results of 24 for search 'Sebastian Schneeweiss', query time: 0.08s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
A novel data mining application to detect safety signals for newly approved medications in routine care of patients with diabetes by Michael Fralick, Martin Kulldorff, Donald Redelmeier, Shirley V. Wang, Seanna Vine, Sebastian Schneeweiss, Elisabetta Patorno
Published 2021-07-01
Article -
11
-
12
-
13
Medications for chronic obstructive pulmonary disease: a historical non-interventional cohort study with validation against RCT results by Kevin Wing, Elizabeth Williamson, James R Carpenter, Lesley Wise, Sebastian Schneeweiss, Liam Smeeth, Jennifer K Quint, Ian Douglas
Published 2021-08-01
Article -
14
The IMPACT of the COVID-19 Pandemic on Prescription Drug Use in Patients with Psoriasis Vulgaris in Germany by Maria Kahn, Steffeni Papukchieva, Elizabeth Jacyshyn-Owen, Stefan Grimm, Markus Eberl, Sebastian Schneeweiss, Marina Otten, Matthias Augustin, Benjamin Friedrich
Published 2023-09-01
Article -
15
Safety and Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists: Pilot Implementation of a Near‐Real‐Time Monitoring Program in Italy by Flavia Mayer, Ursula Kirchmayer, Paola Coletta, Nera Agabiti, Valeria Belleudi, Giovanna Cappai, Mirko Di Martino, Sebastian Schneeweiss, Marina Davoli, Elisabetta Patorno
Published 2018-03-01
Article -
16
-
17
Durability of Protection Post–Primary COVID-19 Vaccination in the United States by Amanda Zheutlin, Miles Ott, Ran Sun, Natalia Zemlianskaia, Craig S. Meyer, Meagan Rubel, Jennifer Hayden, Breno Neri, Tripthi Kamath, Najat Khan, Sebastian Schneeweiss, Khaled Sarsour
Published 2022-09-01
Article -
18
Linking the Paul Coverdell National Acute Stroke Program to commercial claims to establish a framework for real-world longitudinal stroke research by Ajinkya Pawar, Sebastian Schneeweiss, Jessica M Franklin, Xin Tong, Mary G George, Lee H Schwamm, Helen Mogun, Elisabetta Patorno, Lidia M V R Moura
Article -
19
The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care by Elisabetta Patorno, Mehdi Najafzadeh, Ajinkya Pawar, Jessica M. Franklin, Anouk Déruaz‐Luyet, Kimberly G. Brodovicz, Adrian J. Santiago Ortiz, Lily G. Bessette, Martin Kulldorff, Sebastian Schneeweiss
Published 2020-01-01
Article -
20
Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study by Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz-Luyet, Julie M. Paik, Elisabetta Patorno
Published 2024-03-01
Article